AAAAAA

   
Results: 1-10 |
Results: 10
BROMOCRIPTINE PLUS METFORMIN AMELIORATES SEVERE GLUCOSE-INTOLERANCE AND INSULIN-RESISTANCE INDUCED BY A HIGH-FAT DIET IN HAMSTERS
Authors: CINCOTTA AH SCISLOWSKI P JOSLIN J PREVELIGE R PHANEUF S CINCOTTA SR
Citation: Ah. Cincotta et al., BROMOCRIPTINE PLUS METFORMIN AMELIORATES SEVERE GLUCOSE-INTOLERANCE AND INSULIN-RESISTANCE INDUCED BY A HIGH-FAT DIET IN HAMSTERS, Diabetologia, 41, 1998, pp. 766-766
DOPAMINE AGONIST TREATMENT AMELIORATES THE OBESE HYPERLEPTINEMIC CONDITION IN LETHAL YELLOW (AY A) MICE/
Authors: CINCOTTA AH SCISLOWSKI P PHANEUF S PREVELIGE R JOSLIN J
Citation: Ah. Cincotta et al., DOPAMINE AGONIST TREATMENT AMELIORATES THE OBESE HYPERLEPTINEMIC CONDITION IN LETHAL YELLOW (AY A) MICE/, Diabetes, 47, 1998, pp. 1230-1230
TREATMENT OF OBESITY AND DIABETES IN OB OB AND DB/DB MICE BY DOPAMINERGIC AGONISTS/
Authors: SCISLOWSKI P PHANEUF S TOZZO E LIANG Y LUBKIN M PREVELIGE R CINCOTTA A
Citation: P. Scislowski et al., TREATMENT OF OBESITY AND DIABETES IN OB OB AND DB/DB MICE BY DOPAMINERGIC AGONISTS/, Diabetologia, 40, 1997, pp. 1463-1463
BROMOCRIPTINE SKF38393 TREATMENT IMPROVES PANCREATIC-ISLET FUNCTION IN THE DB/DB MOUSE/
Authors: LUBKIN M LIANG Y TOZZO E SCISLOWSKI P PHANEUF S PREVELIGE R MEIER A CINCOTTA A
Citation: M. Lubkin et al., BROMOCRIPTINE SKF38393 TREATMENT IMPROVES PANCREATIC-ISLET FUNCTION IN THE DB/DB MOUSE/, Diabetologia, 40, 1997, pp. 1467-1467
BROMOCRIPTINE SKF38393 TREATMENT INHIBITS GLUCONEOGENIC ACTIVITY AND POTENTIATES GLYCOLYTIC ACTIVATION AND NORMALIZES HYPERGLYCEMIA IN THE OB/OB MOUSE/
Authors: SCISLOWSKI P PREVELIGE B CINCOTTA AH
Citation: P. Scislowski et al., BROMOCRIPTINE SKF38393 TREATMENT INHIBITS GLUCONEOGENIC ACTIVITY AND POTENTIATES GLYCOLYTIC ACTIVATION AND NORMALIZES HYPERGLYCEMIA IN THE OB/OB MOUSE/, Diabetes, 46, 1997, pp. 878-878
BROMOCRIPTINE SKF38393 TREATMENT AMELIORATES CIRCADIAN METABOLIC ABNORMALITIES IN OB/OB MICE/
Authors: TOZZO E SCISLOWSKI P PHANEUF S PREVELIGE R
Citation: E. Tozzo et al., BROMOCRIPTINE SKF38393 TREATMENT AMELIORATES CIRCADIAN METABOLIC ABNORMALITIES IN OB/OB MICE/, Diabetes, 46, 1997, pp. 883-883
DOPAMINERGIC D1D2 AGONIST TREATMENT SHIFTS METABOLISM FROM FAT TO GLUCOSE-OXIDATION WHILE REDUCING OBESITY AND HYPERGLYCEMIA IN OB OB MICE/
Authors: TOZZO E SCISLOWSKI P PHANEUF S
Citation: E. Tozzo et al., DOPAMINERGIC D1D2 AGONIST TREATMENT SHIFTS METABOLISM FROM FAT TO GLUCOSE-OXIDATION WHILE REDUCING OBESITY AND HYPERGLYCEMIA IN OB OB MICE/, Diabetes, 46, 1997, pp. 885-885
BROMOCRIPTINE DIRECTLY INHIBITS LIPID AND GLUCOSE OUTPUT IN OBESE HAMSTER HEPATOCYTES
Authors: SCISLOWSKI P PHANEUF S ZHANG Y
Citation: P. Scislowski et al., BROMOCRIPTINE DIRECTLY INHIBITS LIPID AND GLUCOSE OUTPUT IN OBESE HAMSTER HEPATOCYTES, Diabetes, 45, 1996, pp. 340-340
REDUCTION OF BODY-FAT BY BROMOCRIPTINE 5-HYDROXYTRYPTOPHAN (5-HTP) SYNERGISM IN THE LEPTIN DEFICIENT OB/OB MOUSE/
Authors: CINCOTTA E SCISLOWSKI P TOZZO E PHANEUF S MEIER AH CINCOTTA AH
Citation: E. Cincotta et al., REDUCTION OF BODY-FAT BY BROMOCRIPTINE 5-HYDROXYTRYPTOPHAN (5-HTP) SYNERGISM IN THE LEPTIN DEFICIENT OB/OB MOUSE/, Diabetes, 45, 1996, pp. 385-385
BROMOCRIPTINE REVERSES OBESITY WITHOUT INFLUENCING FOOD-CONSUMPTION IN THE SYRIAN-HAMSTER
Authors: SCISLOWSKI P CUENCO G GARRETT L TOZZO E JOSLIN J CASTRO S HODGE S MEIER A
Citation: P. Scislowski et al., BROMOCRIPTINE REVERSES OBESITY WITHOUT INFLUENCING FOOD-CONSUMPTION IN THE SYRIAN-HAMSTER, Diabetes, 45, 1996, pp. 599-599
Risultati: 1-10 |